Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Brandmaier

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuro-Oncology|January 18, 2022
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysisUmberto Tosi, Omri Maayan, Anjile An, et al.
Neuro-Oncology Practice|July 19, 2021
Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysisUmberto Tosi, Miguel E Tusa Lavieri, Anjile An, et al.
European Journal of Radiology|September 3, 2024
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancerDivya Yadav, Silvina P Dutruel, Elisabeth O'Dwyer, et al.
Breast Cancer Research and Treatment|January 13, 2022
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancerGenevieve A Fasano, Solange Bayard, Yalei Chen, et al.
Neuro-Oncology Advances|August 4, 2021
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical centerPeter C Pan, David J Pisapia, Rohan Ramakrishna, et al.
Neuro-Oncology Advances|March 19, 2021
[<sup>68</sup>Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomasSean S Mahase, Diana A Roth O'Brien, Diana No, et al.
AJNR. American Journal of Neuroradiology|February 23, 2026
[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response BiomarkerKellen Vo Vu, Hannah G Otis, Andrew Brandmaier, et al.
European Journal of Radiology|October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesJana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
AJNR. American Journal of Neuroradiology|December 1, 2025
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with GlioblastomaJana Ivanidze, Kellen Vo Vu, Rongwei Fu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuro-Oncology|January 18, 2022
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysisUmberto Tosi, Omri Maayan, Anjile An, et al.
Neuro-Oncology Practice|July 19, 2021
Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysisUmberto Tosi, Miguel E Tusa Lavieri, Anjile An, et al.
European Journal of Radiology|September 3, 2024
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancerDivya Yadav, Silvina P Dutruel, Elisabeth O'Dwyer, et al.
Breast Cancer Research and Treatment|January 13, 2022
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancerGenevieve A Fasano, Solange Bayard, Yalei Chen, et al.
Neuro-Oncology Advances|August 4, 2021
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical centerPeter C Pan, David J Pisapia, Rohan Ramakrishna, et al.
Neuro-Oncology Advances|March 19, 2021
[<sup>68</sup>Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomasSean S Mahase, Diana A Roth O'Brien, Diana No, et al.
AJNR. American Journal of Neuroradiology|February 23, 2026
[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response BiomarkerKellen Vo Vu, Hannah G Otis, Andrew Brandmaier, et al.
European Journal of Radiology|October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesJana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
AJNR. American Journal of Neuroradiology|December 1, 2025
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with GlioblastomaJana Ivanidze, Kellen Vo Vu, Rongwei Fu, et al.
Pageof 2